Liminal BioSciences Inc. EPS - Earnings per Share 2017-2023 | LMNL
Liminal BioSciences Inc. eps - earnings per share from 2017 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Liminal BioSciences Inc. Annual EPS |
| 2022 |
$0.12 |
| 2021 |
$3.43 |
| 2020 |
$-36.06 |
| 2019 |
$-96.54 |
| 2018 |
$-2,080.00 |
| 2017 |
$-1,200.00 |
| 2016 |
$-1,283.80 |
| 2015 |
$-705.00 |
| 2014 |
$0.00 |
| Liminal BioSciences Inc. Quarterly EPS |
| 2023-06-30 |
$-2.19 |
| 2023-03-31 |
$-1.77 |
| 2022-12-31 |
$-1.07 |
| 2022-09-30 |
$5.36 |
| 2022-06-30 |
$-1.49 |
| 2022-03-31 |
$-2.69 |
| 2021-12-31 |
$-4.25 |
| 2021-09-30 |
$21.77 |
| 2021-06-30 |
$-8.71 |
| 2021-03-31 |
$-5.37 |
| 2020-12-31 |
$-11.39 |
| 2020-09-30 |
$-7.36 |
| 2020-06-30 |
$-8.59 |
| 2020-03-31 |
$-8.73 |
| 2019-12-31 |
$274.80 |
| 2019-09-30 |
$-9.62 |
| 2019-06-30 |
$-60.71 |
| 2019-03-31 |
$-301.00 |
| 2018-12-31 |
$-1,070.02 |
| 2018-09-30 |
$-306.00 |
| 2018-06-30 |
$-387.50 |
| 2018-03-31 |
$-316.48 |
| 2017-12-31 |
$-440.76 |
| 2017-09-30 |
$-160.00 |
| 2017-06-30 |
$-297.00 |
| 2017-03-31 |
$-302.24 |
| 2016-12-31 |
$-447.80 |
| 2016-09-30 |
$-307.00 |
| 2016-06-30 |
$-310.00 |
| 2016-03-31 |
$-219.00 |
